ZYNSTEDIA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ZYNSTEDIA Trademark

Serial Number: 97010844

ZYNSTEDIA is a trademark filed by Neurocrine Biosciences, Inc. on September 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

September 3, 2021

Registration Date

Not Registered

Published for Opposition

January 17, 2023

Goods & Services

pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, tardive dyskinesia, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions of the neurological, hormonal, and endocrine systems; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 10, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 30, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 30, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 30, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 27, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 27, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2023 EXRA
SOU EXTENSION 1 GRANTED
Sep 11, 2023 EX1G
SOU EXTENSION 1 FILED
Sep 11, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 11, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 9, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021 NWOS
NEW APPLICATION ENTERED
Sep 7, 2021 NWAP